Clinical Trial Update: NAT2 in Re-challenge of INH in Patients With Hepatitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether NAT2 genotype can guide re-challenge with isoniazid in patients with hepatitis during tuberculosis treatment. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis
• Viral Hepatitis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Tuberculosis, Hepatotoxicity | Phase 4 | Status: UNKNOWN